212 related articles for article (PubMed ID: 20416027)
1. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death.
Tural U; Onder E
Psychiatry Clin Neurosci; 2010 Feb; 64(1):79-87. PubMed ID: 20416027
[TBL] [Abstract][Full Text] [Related]
2. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic malignant syndrome in Mexico.
Montoya A; Ocampo M; Torres-Ruiz A
Can J Clin Pharmacol; 2003; 10(3):111-3. PubMed ID: 14506509
[TBL] [Abstract][Full Text] [Related]
4. [A study of neuroleptic malignant syndrome in the presenium and senium].
Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
[TBL] [Abstract][Full Text] [Related]
5. [Neuroleptic malignant syndrome. Case reports].
Berardi D; Troia M; Veronesi L; Ferrari G
Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
[TBL] [Abstract][Full Text] [Related]
6. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
Lee JW
Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome.
Lee JW
J Clin Psychopharmacol; 2010 Feb; 30(1):3-10. PubMed ID: 20075641
[TBL] [Abstract][Full Text] [Related]
8. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome: need for early diagnosis and therapy.
Khan HM; Syed NA; Sheerani M; Khcalani B; Kamal A; Wasay M
J Ayub Med Coll Abbottabad; 2006; 18(1):17-21. PubMed ID: 16773963
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic malignant syndrome-an 11-year longitudinal case-control study.
Nielsen RE; Wallenstein Jensen SO; Nielsen J
Can J Psychiatry; 2012 Aug; 57(8):512-8. PubMed ID: 22854034
[TBL] [Abstract][Full Text] [Related]
11. [Neuroleptic malignant syndrome].
Murak E
Psychiatr Pol; 1995; 29(3):349-58. PubMed ID: 7652088
[TBL] [Abstract][Full Text] [Related]
12. Clinical risk factors for neuroleptic malignant syndrome.
Berardi D; Dell'Atti M; Amore M; De Ronchi D; Ferrari G
Hum Psychopharmacol; 2002 Mar; 17(2):99-102. PubMed ID: 12404699
[TBL] [Abstract][Full Text] [Related]
13. Patients with neuroleptic malignant syndrome histories: what happens when they are rehospitalized?
Gelenberg AJ; Bellinghausen B; Wojcik JD; Falk WE; Farhadi AM
J Clin Psychiatry; 1989 May; 50(5):178-80. PubMed ID: 2565897
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic malignant syndrome and atypical antipsychotic drugs.
Ananth J; Parameswaran S; Gunatilake S; Burgoyne K; Sidhom T
J Clin Psychiatry; 2004 Apr; 65(4):464-70. PubMed ID: 15119907
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
[TBL] [Abstract][Full Text] [Related]
16. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
Andreassen MD; Pedersen S
Ugeskr Laeger; 2000 Mar; 162(10):1366-70. PubMed ID: 10745673
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome secondary to quetiapine.
Gortney JS; Fagan A; Kissack JC
Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
[TBL] [Abstract][Full Text] [Related]
18. [Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].
Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Casamassima F; Litta A; Mauri M; Cassano GB
Riv Psichiatr; 2012; 47(2):178-85. PubMed ID: 22622253
[TBL] [Abstract][Full Text] [Related]
19. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
Nisijima K; Ishiguro T
J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic malignant syndrome: life-threatening complication of neuroleptic treatment in adolescents with affective disorder.
Joshi PT; Capozzoli JA; Coyle JT
Pediatrics; 1991 Feb; 87(2):235-9. PubMed ID: 1670966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
